These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27568453)

  • 21. Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
    Olin JT; Bhatnagar V; Reyes P; Koumaras B; Meng X; Brannan S
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):419-26. PubMed ID: 19670390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
    Sicras-Mainar A; Vergara J; Leon-Colombo T; Febrer L; Rejas-Gutierrez J
    Rev Neurol; 2006 Oct 16-31; 43(8):449-53. PubMed ID: 17033976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials.
    Tsoi KK; Hirai HW; Chan JY; Kwok TC
    J Am Med Dir Assoc; 2016 Jan; 17(1):24-30. PubMed ID: 26392193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor imagery of gait in non-demented older community-dwellers: performance depends on serum 25-hydroxyvitamin D concentrations.
    Beauchet O; Launay CP; Fantino B; Annweiler C; Allali G
    Age (Dordr); 2015; 37(2):18. PubMed ID: 25701394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-dementia drugs].
    Shimohama S
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():291-6. PubMed ID: 23156523
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical efficacy and safety of akatinol memantine in treatment of mild to moderate Alzheimer disease: a donepezil-controlled, randomized trial].
    Hu HT; Zhang ZX; Yao JL; Yu HZ; Wang YH; Tang HC; Ji CJ; Xu T
    Zhonghua Nei Ke Za Zhi; 2006 Apr; 45(4):277-80. PubMed ID: 16780671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modern therapy for dementia].
    Padberg F; Möller HJ; Bottlender R; Hampel H
    MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem).
    Fereshtehnejad SM; Johnell K; Eriksdotter M
    Drugs Aging; 2014 Mar; 31(3):215-24. PubMed ID: 24497071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial.
    Montero-Odasso M; Muir-Hunter SW; Oteng-Amoako A; Gopaul K; Islam A; Borrie M; Wells J; Speechley M
    J Alzheimers Dis; 2015; 43(1):193-9. PubMed ID: 25079803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study.
    Gareri P; Putignano D; Castagna A; Cotroneo AM; De Palo G; Fabbo A; Forgione L; Giacummo A; Lacava R; Marino S; Simone M; Zurlo A; Putignano S
    J Alzheimers Dis; 2014; 41(2):633-40. PubMed ID: 24643135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
    Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.
    Farlow MR
    Geriatrics; 2004 Jun; 59(6):22-7. PubMed ID: 15224791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Timed Up and Go Test and Future Dementia Onset.
    Lee JE; Shin DW; Jeong SM; Son KY; Cho B; Yoon JL; Park BJ; Kwon IS; Lee J; Kim S
    J Gerontol A Biol Sci Med Sci; 2018 Aug; 73(9):1238-1243. PubMed ID: 29346523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative.
    Allali G; Annweiler C; Blumen HM; Callisaya ML; De Cock AM; Kressig RW; Srikanth V; Steinmetz JP; Verghese J; Beauchet O
    Eur J Neurol; 2016 Mar; 23(3):527-41. PubMed ID: 26662508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.
    Repantis D; Laisney O; Heuser I
    Pharmacol Res; 2010 Jun; 61(6):473-81. PubMed ID: 20193764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of memantine for elderly patients in the mild stage of Alzheimer's and vascular dementia].
    Bachyns'ka NIu; Rozheliuk IF; Polietaieva KM; Kholin VO
    Lik Sprava; 2013; (7):80-96. PubMed ID: 25509921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis.
    Matsunaga S; Kishi T; Iwata N
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25548104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Test-retest reliability and minimal detectable change scores for the timed "up & go" test, the six-minute walk test, and gait speed in people with Alzheimer disease.
    Ries JD; Echternach JL; Nof L; Gagnon Blodgett M
    Phys Ther; 2009 Jun; 89(6):569-79. PubMed ID: 19389792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.